Patents by Inventor Wilfried Dalemans

Wilfried Dalemans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Replication deficient recombinant adenovirus vector
    Patent number: 6136594
    Abstract: The present invention relates to a replication deficient recombinant adenovirus vector in the genome of which is inserted an expression cassette comprising the DNA fragment coding for the human CFTR protein, said DNA fragment being placed under the control of the elements for the expression thereof.The present invention also concerns a vector according to claim 1 wherein in the expression cassette the human CFTR gene is under the control of the endogenous human CFTR promoter.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: October 24, 2000
    Assignee: Transgene S.A.
    Inventors: Wilfried Dalemans, Michel Perricaudet, Leslie Stratford-Perricaudet, Andrea Pavirani
  • Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
    Patent number: 6013638
    Abstract: The present invention relates, in general, to a adenovirus mediated transfer of genes to the lung. In particular, the present invention relates to a method of recombinant, replication-deficient adenovirus mediated transfer of desired genes to the lung whereby desired proteins of interest are produced for local and/or systemic use.
    Type: Grant
    Filed: December 13, 1993
    Date of Patent: January 11, 2000
    Assignees: The United States of America as represented by the Department of Health and Human Services, Transgene S.A.
    Inventors: Ronald G. Crystal, Wilfried Dalemans, Michel Perricaudet, Leslie Stratford-Perricaudet, Andrea Pavirani